You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-ATP6V0D2 (ATP6V0D2) Antibodies

Full name:
anti-ATPase, H+ Transporting, Lysosomal 38kDa, V0 Subunit D2 Antibodies (ATP6V0D2)
On are 16 ATPase, H+ Transporting, Lysosomal 38kDa, V0 Subunit D2 (ATP6V0D2) Antibodies from 7 different suppliers available. Additionally we are shipping ATP6V0D2 Proteins (7) and many more products for this protein. A total of 27 ATP6V0D2 products are currently listed.
1620401A02Rik, AI324824, ATP6D2, V-ATPase, VMA6
list all antibodies Gene Name GeneID UniProt
ATP6V0D2 245972 Q8N8Y2
ATP6V0D2 242341 Q80SY3
ATP6V0D2 297932 Q5FVL0

Show all species

Show all synonyms

Most Popular Reactivities for anti-ATP6V0D2 (ATP6V0D2) Antibodies

Select your species and application

anti-Human ATP6V0D2 Antibodies:

anti-Mouse (Murine) ATP6V0D2 Antibodies:

anti-Rat (Rattus) ATP6V0D2 Antibodies:

All available anti-ATP6V0D2 Antibodies

Go to our pre-filtered search.

Top referenced anti-ATP6V0D2 Antibodies

  1. Cow (Bovine) Polyclonal ATP6V0D2 Primary Antibody for WB - ABIN2786234 : Morel: Neurotransmitter release: the dark side of the vacuolar-H+ATPase. in Biology of the cell / under the auspices of the European Cell Biology Organization 2003 (PubMed)
    Show all 2 references for ABIN2786234

  2. Human Monoclonal ATP6V0D2 Primary Antibody for ELISA, WB - ABIN566966 : Teramachi, Zhou, Subler, Kitagawa, Galson, Dempster, Windle, Kurihara, Roodman: Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2014 (PubMed)

More Antibodies against ATP6V0D2 Interaction Partners

Human ATPase, H+ Transporting, Lysosomal 38kDa, V0 Subunit D2 (ATP6V0D2) interaction partners

  1. these data suggest that Adrm1 (show Adrm1 Antibodies), a new Atp6v0d2-interacting protein, plays an important role in osteoclast differentiation, and in particular the fusion of preosteoclasts.

Mouse (Murine) ATPase, H+ Transporting, Lysosomal 38kDa, V0 Subunit D2 (ATP6V0D2) interaction partners

  1. we propose that PTH (show PTH Antibodies) has a direct effect on osteoblasts and osteoclasts, and that this effect is mediated through PTH1R (show PTH1R Antibodies), thus contributing to bone remodeling

  2. Insulin (show INS Antibodies) significantly activated ERK1/2 (show MAPK1/3 Antibodies) MAP kinase (show MAPK1 Antibodies) as well as markedly induced the expression of NFATc1 (show NFATC1 Antibodies), an osteoclast marker gene, and Atp6v0d2, an osteoclast fusion-related gene.

  3. V-ATPase (show ATP6V1H Antibodies) has a role in modulating a macrophage phenotype towards tumor-associated macrophages through the action of the a2 isoform of V-ATPase (show ATP6V1H Antibodies)

  4. Luteolin can be effective in reducing bone resorption and that this effect of luteolin may be through disruption of osteoclast V-ATPase a3 (show TCIRG1 Antibodies)-d2 interaction.

  5. PKCdelta (show PKCd Antibodies) deficiency does not perturb formation of the ruffled border or trafficking of lysosomal vesicles containing the vacuolar-ATPase (v-ATPase (show DNAH8 Antibodies)).

  6. these findings suggest that the critical role of ATP6v0d2 may be limited to the control of bone homeostasis under normal development.

  7. The data indicate that integrity of lipid rafts regulates the activity of V-ATPase (show ATP6V1H Antibodies) in osteoclasts, suggesting that cholesterol-lowering agents might be useful for inhibiting osteoclast-dependent bone resorption.

  8. Atp6v0d2 is a regulator of osteoclast fusion and bone formation.

  9. Data indicate for the first time that the NFATc1 (show NFATC1 Antibodies)/Atp6v0d2 and DC-STAMP (show TM7SF4 Antibodies) signaling axis plays a key role in the osteoclast multinucleation process, which is essential for efficient bone resorption.

  10. Atp6v0d2 (d2), an isoform of the d subunit in the V-ATPase (show ATP6V1H Antibodies), showed 5-fold higher expression than that of Atp6v0d1 (show ATP6V0D1 Antibodies) (d1) in mature osteoclasts, indicating a potential function in osteoclastic bone resorption.

ATP6V0D2 Antigen Profile

Antigen Summary

Subunit of the integral membrane V0 complex of vacuolar ATPase. Vacuolar ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells, thus providing most of the energy required for transport processes in the vacuolar system (By similarity). May play a role in coupling of proton transport and ATP hydrolysis. Regulator of osteoclast fusion and bone formation.

Alternative names and synonyms associated with ATP6V0D2

  • ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 (atp6v0d2) antibody
  • ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 (ATP6V0D2) antibody
  • ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2) antibody
  • 1620401A02Rik antibody
  • AI324824 antibody
  • ATP6D2 antibody
  • V-ATPase antibody
  • VMA6 antibody

Protein level used designations for ATP6V0D2

ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d , V-ATPase subunit d 2 , V-type proton ATPase subunit d 2 , vacuolar proton pump subunit d 2 , Vacuolar proton pump subunit d 2 , ATPase, H+ transporting, V0 subunit D , osteoclast-specific vacuolar ATP synthase , vacuolar proton-translocating ATPase d subunit d2 , ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2

447489 Xenopus laevis
420210 Gallus gallus
245972 Homo sapiens
477929 Canis lupus familiaris
511839 Bos taurus
100173359 Pongo abelii
242341 Mus musculus
297932 Rattus norvegicus
Selected quality suppliers for anti-ATP6V0D2 (ATP6V0D2) Antibodies
Did you look for something else?